Sean E. Aeder

Array ( [id] => 7712128 [patent_doc_number] => 20120004289 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-05 [patent_title] => 'ANNEXIN A11 AND ASSOCIATED GENES AS BIOMARKERS FOR CANCER' [patent_app_type] => utility [patent_app_number] => 13/255015 [patent_app_country] => US [patent_app_date] => 2010-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 17342 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13255015 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8759574 [patent_doc_number] => 08420091 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-16 [patent_title] => 'Matriptase protein and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/701566 [patent_app_country] => US [patent_app_date] => 2010-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 47960 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12701566 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6526109 [patent_doc_number] => 20100203529 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'Methods and systems of using exosomes for determining phenotypes' [patent_app_type] => utility [patent_app_number] => 12/658452 [patent_app_country] => US [patent_app_date] => 2010-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 149 [patent_figures_cnt] => 149 [patent_no_of_words] => 80411 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20100203529.pdf [firstpage_image] =>[orig_patent_app_number] => 12658452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7795635 [patent_doc_number] => 08124341 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-28 [patent_title] => 'Genes and polypeptides relating to hepatocellular or colorectal carcinoma' [patent_app_type] => utility [patent_app_number] => 12/699711 [patent_app_country] => US [patent_app_date] => 2010-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 31580 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/124/08124341.pdf [firstpage_image] =>[orig_patent_app_number] => 12699711 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6540847 [patent_doc_number] => 20100204453 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'ANTIBODIES TO TUMOR ASSOCIATED PROTEINS' [patent_app_type] => utility [patent_app_number] => 12/694209 [patent_app_country] => US [patent_app_date] => 2010-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 58 [patent_figures_cnt] => 58 [patent_no_of_words] => 162089 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20100204453.pdf [firstpage_image] =>[orig_patent_app_number] => 12694209 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7685448 [patent_doc_number] => 20100120693 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'MEDICAMENT FOR IMPROVING PROGNOSTIC SURVIVAL IN THERAPY OF MALIGNANT TUMOR' [patent_app_type] => utility [patent_app_number] => 12/691125 [patent_app_country] => US [patent_app_date] => 2010-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4042 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20100120693.pdf [firstpage_image] =>[orig_patent_app_number] => 12691125 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6273103 [patent_doc_number] => 20100255503 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'MARKERS FOR DIAGNOSIS OF CANCER AND ITS USE' [patent_app_type] => utility [patent_app_number] => 12/690437 [patent_app_country] => US [patent_app_date] => 2010-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 12340 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20100255503.pdf [firstpage_image] =>[orig_patent_app_number] => 12690437 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6382796 [patent_doc_number] => 20100317003 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-16 [patent_title] => 'NOVEL COMPOSITIONS AND METHODS IN CANCER WITH ALTERED EXPRESSION OF KCNJ9' [patent_app_type] => utility [patent_app_number] => 12/687837 [patent_app_country] => US [patent_app_date] => 2010-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 24247 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20100317003.pdf [firstpage_image] =>[orig_patent_app_number] => 12687837 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7657245 [patent_doc_number] => 20110306514 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'RATIO BASED BIOMARKERS AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/144474 [patent_app_country] => US [patent_app_date] => 2010-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 36525 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20110306514.pdf [firstpage_image] =>[orig_patent_app_number] => 13144474 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7573095 [patent_doc_number] => 20110268751 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => 'Weekly Dosing Regimens for Anti-CD30 VC-PAB-MMAE Antibody Drug-Conjugates' [patent_app_type] => utility [patent_app_number] => 13/143338 [patent_app_country] => US [patent_app_date] => 2010-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14459 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0268/20110268751.pdf [firstpage_image] =>[orig_patent_app_number] => 13143338 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8363836 [patent_doc_number] => 08252903 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-28 [patent_title] => 'Human sarcoma-associated antigens' [patent_app_type] => utility [patent_app_number] => 12/683374 [patent_app_country] => US [patent_app_date] => 2010-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 38402 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12683374 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7511392 [patent_doc_number] => 20110257102 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'COMPOSITIONS AND METHODS OF TREATING CANCER' [patent_app_type] => utility [patent_app_number] => 13/141437 [patent_app_country] => US [patent_app_date] => 2009-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 26843 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20110257102.pdf [firstpage_image] =>[orig_patent_app_number] => 13141437 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4596437 [patent_doc_number] => 07982004 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-19 [patent_title] => 'Nucleic acid and corresponding protein entitled 161P5C5 useful in treatment and detection of cancer' [patent_app_type] => utility [patent_app_number] => 12/646863 [patent_app_country] => US [patent_app_date] => 2009-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 33 [patent_no_of_words] => 92913 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/982/07982004.pdf [firstpage_image] =>[orig_patent_app_number] => 12646863 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 91693 [patent_doc_number] => 07736861 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-06-15 [patent_title] => 'Tivozanib response prediction' [patent_app_type] => utility [patent_app_number] => 12/645355 [patent_app_country] => US [patent_app_date] => 2009-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7457 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/736/07736861.pdf [firstpage_image] =>[orig_patent_app_number] => 12645355 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6459873 [patent_doc_number] => 20100190200 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-29 [patent_title] => 'Diagnosis of Gynecological Neoplasms By Detecting The Levels of Oviduct-Specific Glycoprotein' [patent_app_type] => utility [patent_app_number] => 12/643423 [patent_app_country] => US [patent_app_date] => 2009-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8536 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20100190200.pdf [firstpage_image] =>[orig_patent_app_number] => 12643423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6615598 [patent_doc_number] => 20100323921 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'MOLECULAR PROGNOSTIC SIGNATURE FOR PREDICTING BREAST CANCER METASTASIS, AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/638040 [patent_app_country] => US [patent_app_date] => 2009-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 28003 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0323/20100323921.pdf [firstpage_image] =>[orig_patent_app_number] => 12638040 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7733627 [patent_doc_number] => 20120015973 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'MEK MUTATIONS CONFERRING RESISTANCE TO MEK INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/139060 [patent_app_country] => US [patent_app_date] => 2009-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 38049 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20120015973.pdf [firstpage_image] =>[orig_patent_app_number] => 13139060 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6495884 [patent_doc_number] => 20100093840 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'Human Sef isoforms and methods of using same for cancer diagnosis and gene therapy' [patent_app_type] => utility [patent_app_number] => 12/591960 [patent_app_country] => US [patent_app_date] => 2009-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 32635 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20100093840.pdf [firstpage_image] =>[orig_patent_app_number] => 12591960 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6539075 [patent_doc_number] => 20100124755 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-20 [patent_title] => 'PROSTATE CANCER AND MELANOMA ANTIGENS' [patent_app_type] => utility [patent_app_number] => 12/629686 [patent_app_country] => US [patent_app_date] => 2009-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8472 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20100124755.pdf [firstpage_image] =>[orig_patent_app_number] => 12629686 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7685453 [patent_doc_number] => 20100120688 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'ErbB Interface Peptidomimetics And Methods Of Use Thereof' [patent_app_type] => utility [patent_app_number] => 12/625706 [patent_app_country] => US [patent_app_date] => 2009-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 28433 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20100120688.pdf [firstpage_image] =>[orig_patent_app_number] => 12625706 [rel_patent_id] =>[rel_patent_doc_number] =>)